WIL Research Increases European Safety Assessment Capacity With New Site in Schaijk, Netherlands
WIL Research , a leading global Contract Research Organization (CRO) in the pharmaceutical, chemical and agrochemical industries, today announced the opening of a new safety assessment facility in Schaijk, Netherlands. In response to the increasing demand for outsourced safety assessment and services, the Schaijk site, located 18km (approximately 11 miles) from WIL Research’s main Netherlands site in Den Bosch, offers a modern, state-of-the-art facility built upon a former pharmaceutical company laboratory.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151201005127/en/
In efforts to support the rapid increase in demand from chemical, agrochemical and pharmaceutical clients, WIL Research attained the new site to allow for additional high-quality capacity, study management and an enhanced reporting turnaround time.
“Our number one priority is to arm our clients with the vital information and resources needed to progress,” said Wilbert Frieling, D.V.M., senior vice president of European Operations. “With increases in both toxicology and analytical services capacity, and leveraging our significant experience in Den Bosch, we can offer our clients more rapid study starts and reporting timelines. The addition of the Schaijk location enhances a strong center of excellence here in The Netherlands serving both global and local clients.”
WIL Research now has approximately 1,400 staff worldwide with laboratories in the United States and Europe and sales and regulatory support in Asia. For more information about WIL Research, please visit www.wilresearch.com .
About WIL Research
WIL Research is an interdisciplinary non-clinical contract research organization providing product safety and toxicological assessment research and services to the international pharmaceutical, biotechnology, chemical, agricultural, veterinary, food and consumer products industries.
Find out more about WIL Research at www.wilresearch.com .
Chempetitive Group for WIL Research
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PIERRE-FABRE23.6.2018 13:02 | pressemeddelelse
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress
SERVIER23.6.2018 10:12 | pressemeddelelse
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho
SOFTOMOTIVE22.6.2018 17:15 | pressemeddelelse
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA
TX-ASCEND-PERFORMANCE22.6.2018 16:02 | pressemeddelelse
Ascend Performance Materials Announces Price Increase for Intermediate Materials
DELTICOM-AG/MOTO-TYRES.C22.6.2018 15:43 | pressemeddelelse
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk
BOEHRINGER-INGELHEIM22.6.2018 14:02 | pressemeddelelse
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum